The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Research Methods · N-of-1 designs · continued

An ABAB design with a data table and honest limitations — a second dataset posts 91–119

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.

IA
i.aranda_esTL2Translator · ES22 Mar 2026#91

ABAB design: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to know which.

0 likes 4mo
II
i.ilungaTL222 Mar 2026#92

A single-person experiment can be genuinely informative if it has a pre-specified outcome, a defined period, and a plan written before the data arrives. Most accounts here have none of those.

It is a small point and it changes the answer, which is an awkward combination.

20 likes 4mo
SG
s.grigorescuTL2Member23 Mar 2026 · edited#93
t.demir, post #56: Post #54 answers the question as asked. The question underneath it is different. A rolling mean over several days is far more informative than any single reading for anything that varies day to day, which is nearly everything. I would put the burden of proof on the interesting explanation, not the dull one. Go to post

On ABAB design the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.

5 likes in reply to #56 4mo
SR
sa.rasmussenTL223 Mar 2026#94

Post #91 answers the question as asked. The question underneath it is different.

ABAB design looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.

0 likes 4mo
SC
s.chowdhuryTL3Regular23 Mar 2026#95

Post #91 put the caveat in the right place and I want to underline it.

Order effects matter. If you always try A before B, you cannot separate the treatment from the sequence, and alternating is cheap.

If anyone can point at the primary source I would be grateful.

0 likes 4mo
AI
an.ibarraTL223 Mar 2026#96
m.yildiz, post #79: I would keep ABAB design and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why the last one went badly. Go to post

Where I would push back on the ABAB design consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.

27 likes in reply to #79 4mo
SL
sleep_logTL2Regular24 Mar 2026#97
baseline_table, post #49: Order effects matter. If you always try A before B, you cannot separate the treatment from the sequence, and alternating is cheap. Posting it because the silence on this was starting to look like agreement. Go to post

Blinding yourself is harder than it sounds and is not impossible. Somebody else preparing labelled containers is the usual approach and it requires a second person you trust.

This has been discussed before and I could not find the thread, so, again.

8 likes in reply to #49 4mo
LV
l.vukovicTL224 Mar 2026#98

Having read the whole ABAB design thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby one instead.

2 likes 4mo
TH
TL4_HalvorsenTL4Leader · Journal club24 Mar 2026#99

Where I part company with post #95, and it is a narrow parting.

Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a week-long half-life, roughly a month is needed to reach baseline. Using that washout period in a before-after design strengthens the inference.

0 likes 4mo
RE
r.ekstromTL224 Mar 2026#100
first_vial, post #72: ABAB design is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring. Go to post

Post #99 is the version of this I will quote in future. One addition.

Filing a mild objection to the consensus on ABAB design. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.

0 likes in reply to #72 4mo
AB
a.batistaTL225 Mar 2026#101
s.lindqvist, post #77: It does not tell you about anybody else, which is why aggregating these accounts does not produce evidence of the kind people want it to. That is what I would do. It may not be what is correct. Go to post

Multiple outcomes measured without a primary one means something will move. Nominate the primary in advance and report the rest as secondary.

The literature is thinner on this than the confidence in the thread implies.

33 likes in reply to #77 4mo
AN
a.nwosuTL225 Mar 2026 · edited#102
t.ndiaye, post #55: Saving this. It is the version I will quote when the question comes round again. Go to post

Reporting the whole series rather than the interesting segment is the discipline that makes personal data worth reading. Selective reporting is the default without effort.

If this contradicts something upthread, the upthread version may well be the better one.

17 likes in reply to #55 4mo
DT
d.tammTL225 Mar 2026#103

Where I have landed on ABAB design, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has borrowed it from somewhere that did not measure it.

3 likes 4mo
AZ
a.zamoraTL226 Mar 2026#104

The arithmetic in post #103 is right; the assumption feeding it is the part to check.

Worth separating ABAB design as a question about the compound from ABAB design as a question about the documentation. They get answered by different people and only one of them is answerable here.

0 likes 4mo
OV
o.vogelTL226 Mar 2026#105
i.aranda_es, post #91: ABAB design: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to know which. Go to post

Where I part company with post #103, and it is a narrow parting.

When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.

24 likes in reply to #91 4mo
MD
m.duarteTL226 Mar 2026#106

Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.

Not the whole picture, but the part of it I can speak to.

11 likes 4mo
NN
n.norgaardTL226 Mar 2026#107

No disagreement from me. Posting only so the question does not look ignored.

1 like 4mo
MS
m.stephanopoulosTL3Regular27 Mar 2026#108

I would put moderate confidence on the mainstream reading of ABAB design and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.

0 likes 4mo
BN
b.nwosuTL227 Mar 2026#109
m.duarte, post #106: Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid. Not the whole picture, but the part of it I can speak to. Go to post

Measure the same thing the same way at the same time of day. Most of the noise in personal data is measurement protocol rather than biology.

18 likes in reply to #106 4mo
RS
r.scholtenTL2Member27 Mar 2026#110

Confirming post #108 from a second method, which matters more than confirming it from a second person.

Practical note on ABAB design: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.

7 likes 4mo
RF
r.friskTL227 Mar 2026#111

Acknowledging rather than arguing. The reasoning holds as far as I can follow it.

0 likes 4mo
HF
h.ferrariTL228 Mar 2026#112
EL
e.lehtinenTL228 Mar 2026#113
trough_index, post #51: My understanding of ABAB design is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it. Go to post

Building on post #110 rather than restating it.

A single-person experiment can be genuinely informative if it has a pre-specified outcome, a defined period, and a plan written before the data arrives. Most accounts here have none of those.

21 likes in reply to #51 4mo
BA
b.aaltoTL228 Mar 2026#114
figure_review, post #76: Confirming post #74 from a second method, which matters more than confirming it from a second person. The best thing about this subcategory is that people post their protocols before their results. That order is what keeps it honest. Go to post

Post #113 put the caveat in the right place and I want to underline it.

Withdrawal and reintroduction is the strongest design available to an individual, and it only works for effects that reverse on a timescale you can observe.

0 likes in reply to #76 4mo
K
KForsbergTL2Member29 Mar 2026#115

Genuine question rather than a rhetorical one: has anyone here actually observed ABAB design, as opposed to read about it? The thread is long and I cannot tell.

2 likes 4mo
KK
k.kimaniTL229 Mar 2026#116

Everything in post #113 holds. The case it does not cover is the one I have.

Adding a reference point for ABAB design. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately.

9 likes 4mo
FF
f.fenwickTL3Regular29 Mar 2026 · edited#117
micrograms, post #40: Speaking only to ABAB design as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the variance between people is larger than the effect. Go to post

Taking post #114 at face value and following it one step further.

Expectation effects in an unblinded self-experiment are large and are not a character flaw. Knowing what you expect to find is a reason to design against it.

None of the above is medical advice and I am not qualified to give any.

28 likes in reply to #40 4mo
LA
l.aguirreTL229 Mar 2026#118

Practical answer on ABAB design, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated explanation is needed. It usually is not.

0 likes 4mo
M
MakinenTL2Member30 Mar 2026#119

Post #118 answers the question as asked. The question underneath it is different.

Reporting rather than recommending, on ABAB design. What happened is above. Whether it should have is a different question and not one I am qualified to answer.

5 likes 4mo

Suggested topics

TopicParticipantsRepliesViewsActivity
An ABAB design with a data table and honest limitations
An ABAB design with a data table and honest limitations Writing it up because I had to work it out twice and would rather nobody else did. An honest uncertainty about ABAB design rather than a disguised…
SSDSEF 2 45k 5mo
About the N-of-1 designs category
Designing a personal experiment that could actually change your mind, including washouts and blinding. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
OBDOKAGRIA 4 22k 14h
Designing a personal experiment that could change your mind
Posting this under the heading it deserves: Designing a personal experiment that could change your mind Everything below is what sits behind that. I was wrong about designing a personal experiment in a thread…
MGECFACHG+2 6 695 6mo
Designing a personal experiment that could change your mind — one year on
Designing a personal experiment that could change your mind — one year on — setting out what I have, and where I think it stops being reliable. Two things I would like separated before anyone answers on…
TKNMPMBSMC+74 80 17k 2d
Blinding yourself: practical methods and their limits
On the subject in the title: Blinding yourself: practical methods and their limits Working notes rather than a conclusion. A methods question rather than a substantive one, about blinding yourself. Everyone…
AZMBCRJNC+40 44 33k 5d

Related topics — sharing the tags confounding, effect size, data table

TopicParticipantsRepliesViewsActivity
Second pass at: Historical amylin analogues and what happened to them
Second pass at: Historical amylin analogues and what happened to them — setting out what I have, and where I think it stops being reliable. The question about Historical amylin analogues that I actually want…
ALCIPFBSV+15 19 22k 18mo
Contributing data without breaching anyone's privacy
Contributing data without breaching anyone's privacy Writing it up because I had to work it out twice and would rather nobody else did. Asking about contributing data without breaching directly, because I…
CAMFSRDNEM+65 71 839 5mo
A claim built entirely on a subgroup analysis — what changed since
On the subject in the title: A claim built entirely on a subgroup analysis — what changed since Working notes rather than a conclusion. What changes if the standard account of claim built is wrong? I ask…
AWZCQZ 2 2k 18mo
Comparing prices across jurisdictions without misleading yourself
Comparing prices across jurisdictions without misleading yourself — setting out what I have, and where I think it stops being reliable. Working notes on comparing prices across jurisdictions rather than a…
LCGFVTPOO+78 83 33k 1mo
Follow-up: Subcutaneous absorption kinetics and site differences
Subcutaneous absorption kinetics and site differences — setting out what I have, and where I think it stops being reliable. A follow-up question about Subcutaneous absorption kinetics and site that I did not…
HCFPNVBICM 4 9.9k 10mo